These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 15855245)
1. Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors. Spinler SA; Nutescu EA; Smythe MA; Wittkowsky AK Ann Pharmacother; 2005 Jun; 39(6):1049-55. PubMed ID: 15855245 [TBL] [Abstract][Full Text] [Related]
2. Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin. Spinler SA; Wittkowsky AK; Nutescu EA; Smythe MA Ann Pharmacother; 2005; 39(7-8):1275-85. PubMed ID: 15956240 [TBL] [Abstract][Full Text] [Related]
3. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95). Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081 [TBL] [Abstract][Full Text] [Related]
4. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Gosselin R; Owings JT; White RH; Hutchinson R; Branch J; Mahackian K; Johnston M; Larkin EC Thromb Haemost; 2000 May; 83(5):698-703. PubMed ID: 10823265 [TBL] [Abstract][Full Text] [Related]
5. The reliability of point-of-care prothrombin time testing. A comparison of CoaguChek S and XS INR measurements with hospital laboratory monitoring. Ryan F; O'Shea S; Byrne S Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e26-33. PubMed ID: 19032373 [TBL] [Abstract][Full Text] [Related]
6. Clinical impact of point-of-care vs laboratory measurement of anticoagulation. Sunderji R; Gin K; Shalansky K; Carter C; Chambers K; Davies C; Schwartz L; Fung A Am J Clin Pathol; 2005 Feb; 123(2):184-8. PubMed ID: 15842040 [TBL] [Abstract][Full Text] [Related]
7. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin. Bauman ME; Black KL; Massicotte MP; Bauman ML; Kuhle S; Howlett-Clyne S; Cembrowski GS; Bajzar L Thromb Haemost; 2008 Jun; 99(6):1097-103. PubMed ID: 18521514 [TBL] [Abstract][Full Text] [Related]
8. The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients. Lawrie AS; Hills J; Longair I; Green L; Gardiner C; Machin SJ; Cohen H Thromb Res; 2012 Jul; 130(1):110-4. PubMed ID: 21937093 [TBL] [Abstract][Full Text] [Related]
9. Results of the performance verification of the CoaguChek XS system. Plesch W; Wolf T; Breitenbeck N; Dikkeschei LD; Cervero A; Perez PL; van den Besselaar AM Thromb Res; 2008; 123(2):381-9. PubMed ID: 18585761 [TBL] [Abstract][Full Text] [Related]
10. Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting. Sobieraj-Teague M; Daniel D; Farrelly B; Coghlan D; Gallus A Thromb Res; 2009 Apr; 123(6):909-13. PubMed ID: 19042011 [TBL] [Abstract][Full Text] [Related]
11. Home prothrombin time monitoring: a literature analysis. Yang DT; Robetorye RS; Rodgers GM Am J Hematol; 2004 Oct; 77(2):177-86. PubMed ID: 15389909 [TBL] [Abstract][Full Text] [Related]
12. Feasibility, cost-effectiveness and patients' acceptance of point-of-care INR testing in a hospital-based anticoagulation clinic. Kong MC; Lim TG; Ng HJ; Chan YH; Lee LH Ann Hematol; 2008 Nov; 87(11):905-10. PubMed ID: 18604535 [TBL] [Abstract][Full Text] [Related]
13. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy. Jonsson M; Hillarp A; Svensson P Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149 [TBL] [Abstract][Full Text] [Related]
14. Point of care monitors for oral anticoagulant therapy. Nutescu EA Semin Thromb Hemost; 2004 Dec; 30(6):697-702. PubMed ID: 15630676 [TBL] [Abstract][Full Text] [Related]
15. A Comparative Study of Point-of-Care Prothrombin Time in Cardiopulmonary Bypass Surgery. Okabayashi S; Ogawa S; Tanaka KA; Nishiyama T; Takeshita S; Nakayama Y; Nakajima Y; Sawa T; Mizobe T J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1609-1614. PubMed ID: 29395816 [TBL] [Abstract][Full Text] [Related]
16. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin. Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152 [TBL] [Abstract][Full Text] [Related]
17. [The application of thrombin generation tests to warfarin anticoagulation monitoring]. Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615 [TBL] [Abstract][Full Text] [Related]
18. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation. Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563 [TBL] [Abstract][Full Text] [Related]
19. Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patients. Baruch L; Sherman O Ann Pharmacother; 2013 Sep; 47(9):1210-2. PubMed ID: 24259738 [TBL] [Abstract][Full Text] [Related]
20. Prothrombin measurement using a patient self-testing system. Oral Anticoagulation Monitoring Study Group. Oral Anticoagulation Monitoring Study Group Am J Clin Pathol; 2001 Feb; 115(2):280-7. PubMed ID: 11211618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]